Fundraising Fox
March Biosciences
Houston, US · Founded 2021 · Delaware corporation · 9 known investors
Find your way into March Biosciences
Sign up to see every warm intro you have to March Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the March Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
March Bioscience is a cell therapy company assembling leading scientists and drug developers to advance cell therapy treatments. The company focuses on developing therapeutics in the cell and gene therapy space.
Founders & leadership
March Biosciences was founded in 2021 by Sarah Hein, Maksim Mamonkin, and Malcolm Brenner.
Board
Investors · 9
How we know: Mission Biocapital's portfolio page · the company's own site · funding news · the VCSheet dataset · Not right? Tell us
How we know: the company's own site · a partner's Signal profile · funding news · Not right? Tell us
How we know: Cancer Focus's portfolio page · Not right? Tell us
How we know: Cancer Fund's portfolio page · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: Modi Ventures's portfolio page · Not right? Tell us
How we know: Portal Innovations's portfolio page · Not right? Tell us
How we know: TMC Venture Fund's portfolio page · Not right? Tell us
How we know: funding news · the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$22.1M disclosed across 2 rounds · 2023–2024
▶$22.1MraisedOct 2024 · 22 investors · BiotechnologyRule 506(b)
- Thomas LubyDirector
- Peter OlagunjuDirector
- Joseph PetrosinoDirector
- Sarah HeinDirector, Executive Officer
- Maksim MamonkinDirector, Executive Officer
- Offering amount
- $22.1M
- Amount sold
- $22.1M
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$8.9KraisedSep 2023 · 1 investors · BiotechnologyRule 506(b)
- Sarah HeinExecutive Officer, Director
- Offering amount
- $8.9K
- Amount sold
- $8.9K
- Minimum investment
- $8.9K
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
Companies working in the same space as March Biosciences.
In the news
Frequently asked questions
- What does March Biosciences do?
- March Bioscience is a cell therapy company assembling leading scientists and drug developers to advance cell therapy treatments. The company focuses on developing therapeutics in the cell and gene therapy space.
- Who founded March Biosciences?
- March Biosciences was founded by Sarah Hein, Maksim Mamonkin, Malcolm Brenner in 2021.
- Who are March Biosciences's investors?
- March Biosciences's investors include Mission Biocapital, 4BIO Capital, Cancer Focus, Cancer Fund, Fitz Gate Ventures, Modi Ventures, Portal Innovations, TMC Venture Fund and 1 more.
- How much funding has March Biosciences raised?
- March Biosciences has disclosed $22.1M raised across 2 rounds.
- Where is March Biosciences headquartered?
- March Biosciences is headquartered in Houston, US.